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1. Introduction 
The first derivation of human embryonic stem cells (hESCs) (Thomson et al., 1998) and the 
more recently development of human induced pluripotent stem cells (iPSCs) (Park et al., 
2008; Takahashi et al., 2007; Takahashi & Yamanaka, 2006; Wernig et al., 2007; Yu et al., 
2007) have marked the beginning of a new era in biomedical research. These two types of 
human pluripotent stem cells (hPSCs) are characterized by an unlimited capacity to self-
renew while retaining their potential to differentiate into almost all cell types of the body 
(Odorico et al., 2001; Reubinoff et al., 2000; Silva & Smith, 2008). These remarkable 
properties turn hPSCs into one of the most interesting cell types for toxicology and drug 
discovery, tissue engineering and regenerative medicine (Battey, 2007; Mountford, 2008). In 
fact, work with hPSCs has already provided new and exciting developments that may 
eventually lead to the creation of novel cell-based therapies for the treatment of a wide 
range of human diseases including Parkinson’s and other neurodegenerative diseases, 
diabetes, cardiac and vascular diseases (Kiskinis & Eggan, 2010; Ronaghi et al., 2010). 
However, a major challenge for the widespread application of hPSCs is the development of 
efficient protocols for cryopreservation.  
To date, two techniques are mainly applied for the cryopreservation of hPSCs: conventional 
slow freezing and vitrification. The conventional slow-freezing and rapid-thawing 
procedure using dimethylsulfoxide (DMSO) as a cryoprotectant is the most commonly used 
method (Grout et al., 1990; Meryman, 2007). While this established technique is effective for 
somatic cell lines and even murine embryonic stem cells (mESCs), hematopoietic and 
mesenchymal human stem cells, this is not the case for hPSCs, due to low recovery rates and 
high levels of differentiation (Berz et al., 2007; Reubinoff et al., 2001; Richards et al., 2004; 
Thirumala et al., 2010). In contrast, vitrification of hPSCs by the “open pulled straw” method 
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using high cryoprotectant concentrations together with flash-freezing in liquid nitrogen has 
reported higher cell survival rates  (Li et al., 2010b; Reubinoff et al., 2001; Richards et al., 
2004). However, there are several disadvantages preventing the widespread use of this 
technique. First, high concentrations of cryoprotectors, which are cytotoxic above 4ºC, are 
needed. Second, these procedures are tedious to perform manually. Additionally, as 
vitrification is mostly performed in open pulled straws, contact between the liquid nitrogen 
and the cells is unavoidable, which carries the risk of contamination. Finally, and one of the 
most limiting disadvantages of this technique is that it is clearly unsuited for freezing bulk 
quantities of hPSCs.  
During the last decade, several groups have been studying different approaches to improve 
the above described cryopreservation protocols. In the present work we will review the 
recent advances in the cryopreservation field trying to point out how a better understanding 
of the sensitivity of hPSCs to the cryopreservation process will help to develop more 
efficient protocols.  
1.1 Human pluripotent stem cells  
1.1.1 Human embryonic stem cells  
The pioneering work on mESCs, and later advances in culturing techniques that were 
developed to culture nonhuman primate embryonic stem cell lines eventually led to the first 
successful generation of hESC lines by Thompson and coworkers and two years later by 
Reubinoff and coworkers  (Evans & Kaufman, 1981; Martin, 1981; Reubinoff et al., 2000; 
Thomson et al., 1995; Thomson et al., 1996; Thomson et al., 1998). These hESCs were derived 
from human embryos that were produced by in vitro fertilization for clinical purposes. 
HESC lines were karyotypically normal and maintained the developmental potential to 
contribute to derivatives of all three germ layers, even after clonal derivation and prolonged 
undifferentiated proliferation (Amit et al., 2000). Since then, hundreds of stem cell lines have 
been derived world-wide from morula, later blastocyst stage embryos, fresh and 
cryopreserved supernumerary embryos, single blastomeres and parthenogenetic embryos 
(Klimanskaya et al., 2006; Lin et al., 2007; Mai et al., 2007; Revazova et al., 2007; Stojkovic et 
al., 2004; Strelchenko et al., 2004).  
HESCs grow in tightly packed colonies and maintain defined borders at the periphery of 
colonies. High nucleus to cytoplasm ratio and prominent nucleoli are typical features of 
individual hESCs within colonies. HESCs are also characterized by high telomerase activity 
and expression of a number of cell surface markers and transcription factors including 
stage-specific embryonic antigen (SSEA)-4, SSEA-3, TRA antigens, Oct3/4, Nanog and 
absence of hESCs negative markers such as SSEA-1 (Carpenter et al., 2003; Chambers et al., 
2003; Draper et al., 2004; Heins et al., 2004; Nichols et al., 1998). Functional confirmation of 
the multipotent nature of hESCs is generally achieved by examining their potential to 
differentiate into all three germ layers (ectoderm, mesoderm and endoderm) both in vitro 
and in vivo. In vitro, hESCs are allowed to randomly differentiate as embryoid bodies (EBs), 
which are aggregates of cells grown in suspension culture, followed by 
immunocytochemical analysis, or measurement of expression of genes associated with the 
three germ layers by RT-PCR (Reubinoff et al., 2000). The in vivo test for pluripotency of 
hESCs is normally teratoma formation in immunocompromised mice (Bosma et al., 1983). 
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1.1.2 Human induced pluripotent stem cells  
An important revolution in the stem cell research field was accomplished when several 
groups in different studies demonstrated that using a cocktail of four factors, somatic cells 
could be reprogrammed into iPSCs (Maherali et al., 2007; Okita et al., 2007; Park et al., 2008; 
Takahashi et al., 2007; Takahashi & Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007).  
Consequently, it was shown that such cells could be generated from patient-specific cells for 
a wide variety of diseases (Kiskinis & Eggan, 2010; Raya et al., 2009; Raya et al., 2010) and 
from a wide variety of somatic cell types (Sun et al., 2010). These cells are morphologically 
similar to hESCs, express typical hESC-specific cell surface antigens and genes, differentiate 
into multiple lineages in vitro, and form teratomas containing differentiated derivatives of 
all three primary germ layers when injected into immunocompromised mice. Indeed, these 
new pluripotent cell lines satisfy all the original criteria proposed for hESCs (Thomson et al., 
1998). Nevertheless, some differences have been observed between hESCs and iPSCs (Chin 
et al., 2009); but it remains unclear whether the small percentage of genes that are 
differentially expressed between these two types of hPSCs are shared among different lines 
and whether these differences are biologically significant. 
Developing iPSCs into therapeutic reagents faces a number of practical hurdles, including 
risks associated with cell processing, the difficulty of ensuring the purity and characteristics 
of the reprogrammed population and the safety and efficacy of reprogrammed cells in vivo 
(Condic & Rao, 2008; Rao & Condic, 2008; Rao & Condic, 2009). Moreover, a case of rejection 
has been recently described after iPSCs autologous transplantation (Apostolou & 
Hochedlinger, 2011). Nonetheless, there is cause for considerable optimism that patient-
specific iPSC lines will both enhance the study of human diseases and advance these studies 
toward clinical applications. 
1.2 Cryopreservation of hPSCs 
Cryopreservation is the process of cooling and storing cells, tissues or organs at sub-freezing 
temperatures, below −80°C and typically below −140°C, to maintain viability (Baust et al., 
2009). The freezing process involves complex phenomena of water crystallization and 
changes in solute concentration both outside and inside the cell that can be detrimental to 
cell survival. In addition, exposure to low temperatures has been reported to induce a stress 
response resulting in biomolecular-based cell death for different cell types (Baust et al., 2001; 
Fu et al., 2001; Paasch et al., 2004; Xiao & Dooley, 2003).  
In general, the major steps used in cryopreservation of most cell types can be summarized as 
follows (figure 1): i) harvesting the cells, ii) addition of cryoprotective agents within a carrier 
media to the cell suspension, iii) ice crystal induction in cell suspension following a 
determined cooling rate (ranging from -1 to -10ºC/min), iv) long-term storage at cryogenic 
temperatures (normally in liquid nitrogen), v) rapid thawing by warming the cell 
suspension in a 37-40ºC water bath, vi) removal of cryoprotective agent by centrifugation 
and vii) seeding down the cells to allow culture growth (Gao et al., 1998; Hubel, 1997).  
Cryoinjury can be due to one or a combination of the following processes: 1) cytotoxicity of 
cryoprotective agents (Muldrew & McGann, 1994; Schneider & Maurer, 1983); 2) osmotic 
injury due to excursion of cryoprotective agents upon freeze-thawing (Gao et al., 1995; 
Mazur & Schneider, 1986); 3) intracellular ice formation in the cooling process (Fujikawa, 
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1980; Mazur et al., 1972) and 4) recrystallization of the intracellular ice during the warming 
process (Mazur & Cole, 1989; Trump et al., 1965). In addition, recent studies have linked 
numerous stress factors associated with cryopreservation to known initiators of molecular-
based apoptotic cell death processes (Baust et al., 2009). 
 
 
Fig. 1. Representative diagram of the main steps involved in a general cryopreservation 
process and the critical variables that should be considered in order to preserve cells with 
good recovery rates.  
2. Sensitivity of hPSCs to cryopreservation 
The techniques employed for the cryopreservation of hPSCs which include slow freezing-
rapid thawing and vitrification, have been shown to be refractory for these cells that present 
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very low survival rates (5-20% and 25-75% respectively) and many of the cells that do 
survive differentiate upon thawing and expansion (Reubinoff et al., 2001; Richards et al., 
2004). The low efficiency of hPSCs cryopreservation has been attributed, in part, to the 
highly “cooperative” nature of these cells (as comparable with mESCs), which appear to 
require intimate physical contact between them within the colony (to permit cell-cell 
signaling) and an optimum clump size of about 100-500 cells during cryopreservation and 
serial passage (Amit et al., 2000; Reubinoff et al., 2000). All these statements mean that we 
are dealing with a cell type that presents extremely high sensitivity to cryopreservation. 
Therefore, the arising questions are: why are hPSCs so vulnerable to the cryopreservation 
process? And which are the processes involved in the low survival rates of hPSCs after 
cryopreservation?  
Heng et al postulated for the first time that apoptosis instead of cellular necrosis, was the 
major mechanism inducing the loss of viability of cryopreserved hESCs during freeze-
thawing with conventional slow-cooling protocols (Heng et al., 2006). They showed that 
most of the cells were viable (~98%) immediately after thawing (determined by the Trypan 
blue dye exclusion method) and that cell viability was gradually decreasing with time in 
culture at 37ºC. Moreover, the kinetics of cell death could be reversibly slowed by a 
reduction in the temperature at which the cells were held post-thaw, indicating an apoptotic 
mechanism for cell death rather than an unregulated necrotic process. Based on these 
previous results, Xu et al investigated the apoptotic pathways activated during 
cryopreservation (Xu et al., 2010a). They described that the largest effect observed, mainly 
due to the freezing step, was an increase in the level of reactive oxygen species in hESCs. 
This presumably leads to the activation and translocation of p53 as strong expression of this 
protein was seen in the nucleus of thawed cells. Consequently, Caspase 9 was activated and 
a significant increase was also observed after thawing. In addition, Caspase 8 activity 
showed a similar increase post-thaw, indicating the possible activation of the extrinsic 
apoptotic pathway. They also stated that the elevated levels of F-actin observed during 
freezing could result in changes in apoptotic signals. These results led the authors to 
conclude that apoptosis in cryopreserved hESCs was induced through both, the intrinsic 
and extrinsic pathways (Xu et al., 2010a).   
However, a remaining question is unanswered: why hPSCs are so sensitive to apoptosis 
compared to mESCs or other cell lines? In order to answer this issue, Wagh et al performed 
detailed microarray studies on hESCs at different time points after thawing and compared 
their transcriptomes with control cells that did not go through the cryopreservation process 
(Wagh et al., 2011). Viability, stemness, colony morphology and proliferation were also 
monitored at different times post-thawing. They observed a full recovery of the phenotypes 
of cryopreserved hESCs after 5 days of cultivation. However, the number of colonies was 
significantly smaller in the frozen hESCs compared to control groups. Furthermore, the 
colony growth rate was also reduced. Gene expression analysis showed very similar 
transcriptomes for the surviving fraction of 30 minutes frozen-thawed hESCs and the 
control unfrozen cells. Therefore, they concluded that the transcriptome of the surviving 
hESCs is preserved during cryopreservation. On the other hand, increases in the number of 
the up- and down-regulated genes occur continuously within 24 h after thawing and 
culturing, and those genes are declined or maintained within 48 h. This observation favored 
the hypothesis that physical cellular damage induced by freezing and/or thawing inhibits 
proper attachment during cultivation resulting in an induction of anoikis apoptotic cell 
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death despite an almost stable transcriptome. Supporting this theory the analysis of the 
microarray showed differences in the expression of genes involved in cell communication, 
cell growth and maintenance, cell death, cell differentiation and cell proliferation (Wagh et 
al., 2011).  In agreement, Li et al showed that increased cellular adhesion induced by the Rho 
associated kinase (ROCK) inhibitor Y-27632 enhances the survival of single hESCs after 
thawing (Li et al., 2009). To demonstrate this, they treated cryopreserved hESCs 
simultaneously with Y-27632 and EGTA, a calcium chelant that disrupts cadherin activity 
and therefore cell adhesion. This double treatment significantly reduced the capacity of 
hESCs to form colonies and cell viability after thawing (Li et al., 2009). These results point to 
a high sensitivity of cryopreserved hPSCs to the loss of adherence between cells and/or to 
the substrate, resulting in a detachment induced apoptosis or anoikis.  
According to the high differentiation rates experienced by hPSCs after cryopreservation, 
Wagh et al observed a down-regulation of pluripotency markers such as nanog, sox2 or klf4 
(Wagh et al., 2011). In agreement with these results, it has been shown that the pluripotency 
marker Oct-4 was significantly decreased after culturing cryopreserved hESCs for several 
days (Katkov et al., 2006). In addition, the freeze-thaw stress increases the expression of 
several genes involved in the differentiation processes such as embryonic morphogenesis, 
neurogenesis, ossification, tissue morphogenesis, regeneration and vasculature development 
(Wagh et al., 2011). 
3. Improvement of existing cryopreservation protocols 
Many laboratories have been working over the last 10 years in the development of new 
cryoprerservation protocols for hPSCs. The main aim of the vast majority of these protocols 
has been the improvement of cell recovery including: an enhancement of cell survival and a 
reduction of cell differentiation. To this end different approaches have been adopted: 
development of new cryopreservation protocols such as vitrification, usage of different 
cryoprotective agents or molecules to improve survival, xeno-free cryopreservation media, 
cryopreservation of adherent hPSC colonies or single cells and/or utilization of devices to 
control changes in temperature. Although each of these works (summed up bellow), 
provide some improvements in hPSCs recovery after cryopreservation, not many of them 
have addressed the key question: how the changes introduced in the cryopreservation 
protocols contribute to the enhancement in cell recovery?   
3.1 Vitrification and optimizations of the technique 
One of the first attempts to overcome the low survival rates experienced by hPSCs after 
cryopreservation using the standard slow freezing-rapid thawing method was the 
adaptation of the vitrification protocol. This technique was developed for the 
cryopreservation of bovine ova and embryos (Vajta et al., 1998) and it was successfully 
adapted for hESCs freezing by Reubinoff and colleagues some years ago (Reubinoff et al., 
2001). The protocol requires stepwise exposure of colony fragments to two vitrification 
solutions of increasing cryoprotectant concentrations. This exposure is sequential and brief 
(60 and 26 seconds respectively either at room temperature or at 37ºC). The common 
components of the vitrification medium are DMSO and ethylene glycol. The composition of 
the vehicle solution varies, with differences in sucrose concentration, the presence or 
absence of serum and the buffer used. Using mixtures of cryoprotectants helps to reduce the 
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intrinsic toxicity of each, and the method published by Reubinoff et al utilized 20% DMSO, 
20% ethylene glycol and 0.5 mol/l sucrose (Reubinoff et al., 2001). However, no studies have 
been reported so far to determine the permeability of the cells (or colony fragments) to 
either cryoprotectant, or the intrinsic toxicity of these components to hESCs (Hunt, 2011).  
Extremely rapid cooling rates are required to achieve vitrification using this two-component 
system. This is accomplished by direct immersion into liquid nitrogen of open-pulled straws 
containing small droplets (typically 1-20 µl) of vitrification solution within which the colony 
fragments (< 10) are held. Straws are then generally transferred to liquid nitrogen for long 
term storage (Vajta et al., 1997; Vajta et al., 1998). 
The thawing process has to be as well, as rapid as possible to avoid ice crystallization. This 
is accomplished by direct immersion of the vitrified samples into pre-warmed culture 
medium containing sucrose, followed by stepwise elution of the cryopreotectants using 
sucrose as an osmotic buffer. An alternative method with direct exposure to growth 
medium without stepwise elution of the cryoprotectants has also been used with no 
noticeable deleterious effects (Hunt & Timmons, 2007; Reubinoff et al., 2001). 
Vitrification has been adopted by many groups as the method of choice for hPSCs 
cryopreservation based on several comparative studies reporting recovery rates of 
undifferentiated colonies of more than 75% after vitrification compared to the 5-10% 
obtained after slow-cooling and rapid thawing (Li et al., 2010b; Reubinoff et al., 2001; 
Richards et al., 2004; Zhou et al., 2004). However, this technique presents some 
limitations: it is labor intensive and technically challenging, it is not suitable for large 
amounts of cells and the contact between the liquid nitrogen and the cells carries the risk 
of contaminations (Vajta & Nagy, 2006). Some attempts to improve these limitations have 
been done so far. One approximation was proposed by Heng et al for the 
cryopreservation of adherent hESCs colonies (Heng et al., 2005). They designed a culture 
plate made of detachable screw-cap culture wells resistant to storage at low temperatures 
in liquid nitrogen envisioned to develop automated systems for handling bulk quantities 
of cells (Heng et al., 2005). Alternatively, a method combining the large holding volume of 
slow-cooling rapid-thawing in cryotubs with the high efficiency of vitrification was 
described by Li et al (Li et al., 2008a). In this protocol hESCs clumps (>70um) were 
harvested after passage and transferred to a nylon cell strainer, exposed to vitrification 
solutions and vitrified by direct immersion in liquid nitrogen. Using this bulk vitrification 
method, 30 times more hESCs clumps (100-150) can be vitrified in a cell strainer compared 
to the open pulled straws. In addition, comparable results to those obtained for the 
classical vitrification method were reported for the recovery rate, the degree of 
differentiation and the maintenance of the pluripotency of the surviving cells (Li et al., 
2008a). A refinement of this technique, using a cryovial fitted with stainless steel mesh, 
produced similar results (Li et al., 2010a). Although this method is easy and efficient to 
perform it still presents the limitation of direct contact of the cells with liquid nitrogen 
increasing the possibility of contamination and cell infection.  
In order to avoid direct contact of the vitrification solution with the liquid nitrogen several 
methods have been developed. Usage of embryo straws sealed in both ends with a 
commercial plastic bag heat sealer was reported by Richards et al (Richards et al., 2004). This 
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improvement of the cryopreservation technique presents a similar yield of hESCs recovery 
after thawing with low differentiation rates comparable with the results of Reubinoff et al 
(Reubinoff et al., 2001). The usage of cryovials for vitrification has also been explored showing 
interesting results. Nishigaki et al used a DMSO-based and serum-free vitrification medium to 
cryopreserve iPSCs in cryovials (Nishigaki et al., 2011). They compared various vitrification 
solutions containing different concentrations of DMSO, ethylene glycol and polyethylene 
glycol with knockout serum replacement (KSR) in both DMEM and Euro-collins vehicle 
solutions. Analysis of the thermal properties of the cryopreservation solutions during the 
cooling process by differential scanning calorimetry (DSC) indicated that they would vitrify at 
an optimal cooling rate of ~ -125 ºC/min. Recovery rates between 20-30% are described one 
day after thawing using 40% ethylene glycol and 10% polyethylene glycol in Euro-Collins 
solution. Furthermore, cryopreserved cells express undifferentiation markers and keep 
pluripotency (Nishigaki et al., 2011). Therefore, using this protocol the vitrification of large 
amounts of cells is feasible and avoids the risk of contamination.  
3.2 Usage of different cryoprotective agents and vehicles 
During the cryopreservation course, as the cell suspension is cooled below the freezing point, 
ice crystals form and the concentration of the solutes in the suspension increases, being both 
processes damaging for the cells. Cryoprotective agents (CPAs) are necessary to minimize or 
prevent the damage associated with the freezing process. The mechanisms providing this 
protection in slow cooling-rapid thawing protocols, although not completely understood, 
appear to work primarily by altering the physical conditions of both the ice and the solutions 
immediately surrounding (external to) the cells. In contrast, vitrification overcomes the 
problems associated with ice crystallization in a different manner. Here cryoprotectants are 
used in high concentrations preventing ice formation entirely (Baust et al., 2009; Hunt, 2011). 
Different CPAs have been identified so far to be used for the cryopreservation of 
mammalian cells (Klebe & Mancuso, 1983; Matsumura et al., 2010); however, the two most 
commonly used substances are glycerol and DMSO. Other substances used include sugars, 
polymers, alcohols and proteins. CPAs can be divided roughly into two different categories: 
(1) permeating CPAs: substances that permeate the cell membrane (e.g. DMSO and 
glycerol); and (2) nonpermeating CPAs: impermeable substances (e.g. polyethylenen glycol 
and trehalose); both types present a different impact on the freezing process. Permeating 
CPAs have a low molecular weight and thus can penetrate the cell membrane and gradually 
substitute the water present in the cells. The osmolality of the cells is thereby increased, and 
subsequently, the percentage of extracellular water that can form ice crystals before reaching 
the osmotic equilibrium is reduced and total dehydration of the cells is prevented. 
Nonpermeating CPAs cannot penetrate the cell membrane and stabilize the cell by forming 
a viscous glassy shell around its surface (Hubel, 1997; Karlsson, 2002; Karlsson & Toner, 
1996; Meryman, 2007). Therefore, the selection of an appropriate CPA or a combination of 
them used in optimal concentrations within an effective vehicle solution will determine the 
efficiency of the cryopreservation process for a given cell type. In this sense, alternatives to 
DMSO as the cryoprotectant of choice for hPSCs have been tested due to the known effect of 
this solvent on inducing differentiation and cytotoxicity (Adler et al., 2006). See Table 1 for 
an overview of CPAs and freezing vehicles used in different protocols describe here. 
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Trehalose is a natural disaccharide that has been selected as an attractive CPA for several 
reasons. First of all, it has been shown to be effective in mammalian cell stabilization at low 
temperatures and water contents. Secondly, trehalose preserves cell viability by different 
mechanisms than DMSO (Crowe et al., 2001; Sum et al., 2003; Sum & de Pablo, 2003). 
Finally, trehalose addition to the cryopreservation medium containing DMSO and fetal 
bovine serum (FBS) has been proven to increase the viability of hematopoietic precursor 
cells from 7% to 20% and improved membrane integrity in cryopreserved fetal skin cells 
(Erdag et al., 2002; Zhang et al., 2003).  Ji et al showed that trehalose loading into adherent 
colonies of hESCs prior to cryopreservation results in small, but significant improvements in 
cell viability when combined with DMSO treatment and high FBS concentrations (Ji et al., 
2004). In the same line of results, it has been demonstrated that trehalose addition to the 
freezing and post-thawing medium of hESC colonies cryopreserved in suspension in 
freezing medium containing 10% DMSO, increased the recovery rate by ~3 folds (from 15 to 
48%) (Wu et al., 2005). These results suggested that the protective mechanism of trehalose 
addition might be the reduction of osmotic changes during the freezing and thawing 
process, although this hypothesis has not been demonstrated. The addition of trehalose did 
not affect the normal karyotype of the cells neither their pluripotency capacity tested by 
teratoma formation (Wu et al., 2005). 
A comparison between four different types of CPAs for iPSCs cryopreservation has recently 
been described: DMSO, ethylene glycol, propylene glycol and glycerol (Katkov et al., 2011). 
Interestingly, the toxicity of these four CPAs was analyzed after 30 minutes exposure of a 
10% CPA solution at 37ºC. The results showed that DMSO was the most toxic CPA for iPSCs 
while glycerol was the least harmful being the other two CPAs in between. Surprisingly, the 
protective effect exerted by the same CPAs after cryopreservation of small iPSC clumps by 
the slow cooling-rapid thawing protocol was the opposite, being DMSO the most protective 
CPA together with ethylene glycol while glycerol was the least protective one. The same 
result was obtained when iPSCs previously dissociated with AccutaseTM were 
cryopreserved in the presence of a ROCK inhibitor in combination with the previous 
mentioned CPAs. Therefore, ethylene glycol was selected as the cryoprotectant of choice 
since it presents less toxicity than DMSO and exerts similar levels of protection (Katkov et 
al., 2011). In addition, these results give clear evidence that the low hPSCs recovery rate 
obtained after cryopreservation is mainly caused by the freezing-thawing procedure, rather 
than by the process of CPA addition/removal. 
The combination of different CPAs has also been tested in comparison to the conventional 
freezing solution containing 10% DMSO in slow cooling-rapid freezing protocols. Ha et al 
performed a detailed study about the composition of the cryopreservation medium, initially 
analyzing the impact of both DMSO and FBS concentration in hESCs recovery (Ha et al., 
2005). They reached the conclusion that a combination of 5% DMSO plus 50% FBS was the 
most effective one sustaining survival rates of 10%. Afterwards, they used this freezing 
medium composition as a starting point to test different concentrations of other CPAs such 
as ethylene glycol or glycerol. An increase of 3 fold in the survival rate (around 30%) was 
obtained when using a combination of 5% DMSO + 50% FBS +10% ethylene glycol that was 
selected as the most effective cryopreservation medium. Three passages after thawing 
cryopreserved hESCs retained the key properties and characteristics of hPSCs (Ha et al., 
2005). 
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CPA 
composition 
Freezing 
vehicle 
Addition 
of other 
molecules
Cell 
type 
Cell 
processing
Type of 
culture 
Recovery rate Reference 
10 % EG 
Not 
described
ROCK 
inhibitor 
iPSCs 
Colony 
clumps 
and single 
cells 
MEF feeder 
layer 
~20-50% 
recovery(1) (Katkov et 
al., 2011) 
No 
Adherent 
colonies 
~60% recovery 
(1) 
10% DMSO 
Growth 
medium 
No hESCs 
Colony 
clumps 
MEF feeder 
layer 
60% (30 min) 
<10% (24 h) (2) 
(Wagh et 
al., 2011) 
0-55% 
recovery (16) 
(Li et al., 
2010b) 
ROCK 
inhibitor 
hESCs 
Single cells
Human 
foreskin 
feeder layer
50-60% 
survival(4) 
 
(Martin-
Ibanez et 
al., 2008) 
hESCs  
and 
iPSCs 
MEF feeder 
layer and 
feeder-free 
culture 
7-8 fold 
increase in the 
number of 
recovered cells 
or colonies (8) 
(Claassen 
et al., 2009) 
ROCK 
inhibitor + 
P53 
inhibitor 
hESCs Single cells
MEF feeder 
layer and 
feeder-free 
culture 
~80% 
survival(5) 
(Xu et al., 
2010a) 
90% FCS 
ROCK 
inhibitor 
hESCs  
and 
iPSCs 
Single cells
Feeder-free 
culture 
90% viable 
cells(4) 
(Mollamoh
ammadi et 
al., 2009) 
90% KSR 
No hESCs 
Colony 
clumps 
MEF feeder 
layer 
8-53% 
survival(17) 
(Lee et al., 
2010) 
ROCK 
inhibitor 
hESCs 
Colony 
clumps 
MEF feeder 
layer 
85-95% 
survival(6) 
(Li et al., 
2008b) 
Single cells
Feeder-free 
culture 
53-65% (7) 
(Li et al., 
2009) 
90% 
(DMEM/F
12 
+ 20% 
FBS) 
Z-VAD-
FMK 
hESCs 
Adherent 
colonies 
MEF feeder 
layer 
18.7% (11) 
(Heng et 
al., 2007) 
No 
~98% (5 min) 
20-30% 
(90 min) (12) 
(Heng et 
al., 2005) 
60 % 
growth 
medium + 
30%FBS 
No hESCs 
Adherent 
colonies 
(microca-
rriers) 
MEF feeder 
layer and 
feeder-free 
culture 
1.5-1.9 fold 
increase in 
recovery 
rate(13) 
(Nie et al., 
2009) 
5% DMSO 
5% HES 
80% 
(DMEM/ 
F12 + 20% 
KSR) 
No hESCs 
Colony 
clumps 
MEF feeder 
layer 
~80% 
recovery (9) 
(T'joen et 
al., 2011) 
10% DMSO + 
0.2 mol/l 
Trehalose 
90% KSR No hESCs 
Colony 
clumps 
MEF feeder 
layer 
37-48% 
recovery(10) 
(Zhang et 
al., 2003) 
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10% DMSO+ 
35 mM 
Trehalose 
40% 
Growth 
medium + 
50% FBS 
No hESCs 
Adherent 
colonies 
MEF feeder 
layer and 
feeder-free 
culture 
25% viability 
increase in 
respect to 
DMSO alone(14) 
(Ji et al., 
2004) 
7.5% DMSO 
2.5% PEG 
Growth 
medium 
ROCK 
inhibitor + 
P53 
inhibitor 
hESCs 
Single 
Cells 
MEF feeder 
layer and 
feeder-free 
culture 
80-90% 
survival(5) 
 
(Xu et al., 
2010b) 
10% DMSO + 
another 
undisclosed 
CPA 
Phosphate 
buffer 
No 
hESCs  
and 
iPSCs 
Colony 
clumps 
Human 
foreskin 
feeder layer
90-96%  
viability(15) 
(Holm et 
al., 2010) 
5% DMSO 
10% EG 
50%FBS 
and 
DMEM/
F12 
No hESCs 
Colony 
clumps 
MEF feeder 
layer 
30% colony 
recovery (3) 
(Ha et al., 
2005) 
Table 1. Cryoprotectant agents and freezing vehicles used for the cryopreservation of hPSCs 
using the slow-freezing rapid-thawing protocol. The conditions and recovery rates showed 
in the table correspond to the best condition tested in the referenced works. (DMSO: 
dimethyl sulfoxide; EG: ethylene glycol; PEG: polyethylene glycol; HES: 
Hydrosyethylstarch; FBS: fetal bovine serum; FCS: fetal calf serum; KSR: Knockout serum 
replacement; MEF: mouse embryonic fibroblasts). The recovery rates were determined using 
different tests: (1) % cell recovery determined by QUANTA Coulter Counter measurement 
of Calcein-PM+/7AAD-. (2) % viability determined with FDA/EB staining at different time 
points after thawing. (3) Number of colonies 10 days after plating. (4) Cell viability was 
determined counting the number of cells by the Trypan blue exclusion method immediately 
after thawing. (5) Cell viability was determined by FACS using propidium iodide staining 
immediately after thawing. (6) Number of colonies at day 5/total colonies replated. (7) Flow 
cytometry analysis of apoptotis using Anexin V and propidium iodide immediately after 
thawing. (8) Fold increase in the number of recovered cells determined using a Z2 Coulter 
Counter and Size analyzer 4 days after thawing. Fold increase in the number of colonies 
determined by microscopy. (9) Recovery rate was calculated as follows: the amount of 
Grade A+B colonies at day 7 post-thawing versus the amount of frozen Grade A+B colonies. 
(10) Number of colonies 7 days after thawing. (11) MTT assay to measure % survival rate 24 
h post-thawing. (12) Viability determined by Trypan blue exclusion method of adherent 
colonies at different time points after thawing. (13) Recovery was calculated as the number 
of cells one week after thawing divided by the number of cells at the time of freezing. The 
recoveries of hPSCs frozen using microcarriers are normalized to the recoveries of hPSCs 
frozen as free colonies. (14) Cell viability was measured by MTT assay or Alamar Blue assay 
several days after thawing. (15) Viability or percentage of surviving cells was calculated as a 
ratio between live hPSCs after thawing and total number of initially frozen cells. Cells were 
counted using the Trypan blue exclusion method. (16) Recovery rates were estimated as the 
% of attached and undifferentiated clumps counted 7-8 days after-thawing respect to the 
initially frozen. (17) Viability was assessed counting the number of colonies stained for 
alkaline phosphatase. 
A new cryopreservation formula containing 7.5% DMSO plus 2.5% polyethylene glycol was 
analyzed in another work (Xu et al., 2010b). This study resulted in slight but significant 
increase in the hESCs recovery determined by counting the number of cells or colonies in 
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feeder-independent or feeder-dependent culture respectively (Xu et al., 2010b). Recently, an 
alternative cryopreservation medium combining intracellular (5% DMSO) and extracellular 
(5% Hydrosyethylstarch) CPAs has been proven to be highly effective for the 
cryopreservation of small hESC clumps by the classical slow-freezing rapid-thawing 
method. These clumps are obtained by a combination of hESC colony detachment with 
Collagenase IV followed by 5 minutes dissociation using an undisclosed solution. This 
protocol is suitable for handling bulk amounts of hPSCs (T'joen et al., 2011). 
Comparison of different freezing vehicles using DMSO as a cryoprotectant has also been 
studied for the cryopreservation of dissociated hESCs (Mollamohammadi et al., 2009). Three 
preservation media containing 10% DMSO plus: 90% fetal calf serum (FCS), 90% KSR or 
90% hESCs medium containing 20% KSR and ROCK inhibitor were analyzed. The 
percentage of viable cells obtained by the Trypan blue exclusion method after thawing 
showed that cells were better preserved in the presence of 90% FCS as a vehicle (~90%). The 
other two freezing solutions caused lower survival rates (60-80%) (Mollamohammadi et al., 
2009). Following a similar approach, Ha et al studied the impact of different FBS 
concentrations (5, 50 and 95%) in the vehicle freezing solution using a 5% DMSO as a CPA 
(Ha et al., 2005). A decrease in the survival rate is observed as the FBS concentration is 
reduced although no differences were found between 50 and 95%. Therefore, the authors 
established 50% of FBS as the optimal concentration to support hPSCs survival during the 
cryopreservation process (Ha et al., 2005). 
3.3 Addition of molecules to enhance survival 
One of the first molecules studied in the cryopreservation process to enhance cell survival was 
the caspase inhibitor Z-VAD-FMK (Heng et al., 2007). Results obtained in a previous work 
from the same group showing that apoptosis rather than necrosis was the responsible 
mechanism involved in the loss of viability during hESCs cryopreservation encouraged them 
to test a broad-spectrum irreversible inhibitor of caspase enzymes (Heng et al., 2006). Exposure 
to 100 mM Z-VAD-FMK in the freezing solution alone did not significantly enhace the post-
thaw survival rate. However, when Z-VAD-FMK was added to the freezing solution as well as 
to the post-thawing solution a significant enhancement in the cell survival rate (~two fold) was 
observed. Nevertheless, the differentiation rates of cryopreserved hESCs were not reduced 
and therefore the culture recovery was not improved (Heng et al., 2007). Similarly, the 
addition of a specific Caspase-9 inhibitor to the post-thawing recovering medium failed to 
increase hESCs colony formation 4-5 days after thawing, although it did reduce Caspase 8 and 
9 activity 2 h after cryopreservation (Xu et al., 2010a). These results suggested that Caspase 
activity was not the triggering mechanism contributing to the low hPSCs recovery after 
cryopreservation, but it could be a downstream effector. 
A significant improvement in the cryopreservation field came up with the addition of a 
ROCK inhibitor. ROCK have been found to play a role in the regulation of multiple 
biological pathways such as apoptosis, cell cycle, differentiation, cell adhesion as well as 
gene expression (Amano et al., 1997; Hall, 1994; Ishizaki et al., 1997; Krawetz et al., 2009; 
Maekawa et al., 1999). Watanabe et al reported for the first time, that addition of the ROCK 
inhibitor Y-27632 improved the cloning efficiency of dissociated hESCs more than 25-fold 
when the cells were plated at low density (Watanabe et al., 2007). One year later, the same 
inhibitor was tested for the cryopreservation of hESCs. Li et al demonstrated that 10 µM Y-
27632 added to the post-thaw medium during 1 day increased hESCs survival when 
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cryopreserved as small clumps (Li et al., 2008b). In parallel our group reported that 
dissociated hESCs could be cryopreserved in the presence of ROCK inhibitor (Martin-Ibanez 
et al., 2008; Martin-Ibanez et al., 2009). The addition of Y-27632 to the freezing medium did 
not increase the formation of hESCs colonies compared to the control non treated cells 
although it increased cell survival. In contrast, the presence of ROCK inhibitor in the 
post-thawing recovery medium did increase the formation of hESCs colonies significantly 
(50-100 times). The addition of Y-27632 to both, the cryopreservation and the post-thawing 
medium was the condition tested contributing to the highest cell recovery after freezing.   
 
Rock 
inhibitor 
addition 
Type of cell 
and culture 
Cell 
processing 
Recovery rate  
(method of analysis) 
Time of 
analysis 
Reference 
Freezing 
and post-
thawing 
recovery 
media  
(1 day) 
hESCs on 
human 
foresking 
feeders 
Single cells 
50-60% survival 
% survival after thawing 
analyzed by Trypan Blue 
exclusion method 
Immediately 
after thawing 
(Martin-
Ibanez et 
al., 2008) 
hESCs  and 
iPSCs in 
feeder-free 
culture 
Single cells 
60-80% viable cells 
% survival after thawing 
analyzed by Trypan blue 
exclusion method 
Immediately 
after thawing 
(Mollamoh
ammadi et 
al., 2009) 
hESCs on 
MEF feeders 
and feeder-
free culture 
Single cells 
80-90% survival 
% survival after thawing 
analyzed by propidium 
iodide staining 
Immediately 
after thawing 
(Xu et al., 
2010a) 
(Xu et al., 
2010b) 
iPSCs on 
MEF feeders 
Single cells,  
clumps and 
adherent 
colonies 
20-60% recovery depending 
on the type of culture 
% recovery after thawing 
by  QUANTA Coulter 
Counter measurement of 
Calcein-PM+/7AAD- 
Not stated 
(Katkov et 
al., 2011) 
Post-
thawing 
recovery 
medium  
(1 day) 
hESCs on 
MEF feeders 
Colony 
clumps 
85-95% survival 
Number of colonies at day 
5/total colonies replated 
5 days after 
thawing 
(Li et al., 
2008b) 
hESCs  in 
feeder-free 
culture 
Single cells 
53-65% 
Flow citometry analysis of 
apoptosis using Anexin V 
and propidium iodide 
Immediately 
after thawing 
and 24 h after 
thawing 
(Li et al., 
2009) 
Post-
thawing 
recovery 
medium  
(4 days) 
hESCs on 
MEF feeders 
and feeder-
free culture 
Single cells 
7-8 fold increase in the 
number of recovered cells 4 
days after thawing (Z2 
Coulter Counter and Size 
analyzer) 
4 days after 
thawing 
(Claassen et 
al., 2009) 
Post-
thawing 
recovery 
medium 
(2 days) 
iPSCs on 
MEF feeders 
Single cells 
7 fold increase in the 
number of colonies 48 h 
post-thawing 
2 days after 
thawing 
(Claassen et 
al., 2009) 
Table 2. Overview of the ROCK inhibitor treatments tested to improve the recovery rates 
after cryopreservation of hPSCs. Survival rates showed in the table are obtained using the 
best condition tested in the work referenced.   
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Moreover, we described a complete avoidance of hESCs differentiation just after 
cryopreservation showing that most of the colonies expressed the undifferentiation markers: 
Oct-4, nanog, SSEA-4, TRA-1-81 and TRA-1-60. The addition of Y-27632 increased the 
growth rates to control levels, did not affect hESCs normal karyotype and kept their 
pluripotency (Martin-Ibanez et al., 2008). Similar results have been shown not only for 
hESCs but also for iPSCs in both feeder-associated and feeder-free conditions (Claassen et 
al., 2009; Katkov et al., 2011; Mollamohammadi et al., 2009). See table 2 for a sum up of all 
the ROCK inhibitor treatments used for cryopreservation of hPSCs. 
ROCK inhibitors have also been used in combination with other molecules such as Caspase 
inhibitors, p53 inhibitors or Bax inhibitors added always to the post-thawing culture 
medium. Xu et al showed that none of the three combinations pan-Caspase inhibitors + Y-
27632, Caspase 9 inhibitor + Y-27632 and Bax inhibitor + Y-27632 enhanced the protective 
effect of ROCK inhibitor alone for cryopreserved hESCs (Xu et al., 2010a). Only the 
treatment with a p53 inhibitor + Y27632 induced a cell recovery similar to that of ROCK 
inhibitor. However, treatment with p53 alone did not account for an increase in cell survival 
(Xu et al., 2010a). Similar results were obtained by the same group in another report where 
they observed an enhancement of hESCs recovery when cryopreserved in 10% DMSO or 
7.5% DMSO + 2.5% polyethylene glycol and treated with p53 inhibitor + Y-27632 in the post-
thawing medium (Xu et al., 2010b).  
Although most of the works studying the effect of ROCK inhibitor during cryopreservation 
did not address the mechanism of action of this molecule, at least two of them showed some 
interesting results (Li et al., 2009; Xu et al., 2010a). Both of them reported a reduction in hESCs 
apoptosis and/or Caspase activity one day after cryopreservation driven by Y-27632. This is in 
agreement with the previous report of Watanabe et al who pointed to an antiapoptotic role of 
this ROCK inhibitor (Watanabe et al., 2007). In addition, Li et al demonstrated that Y-27632 
treatment increased the adherent properties of cryopreserved hESCs favoring cell aggregate 
formation and adhesion to the substrate. This effect, in turn, prevented anoikis and enhanced 
hESCs survival (Li et al., 2009; Mollamohammadi et al., 2009).  
3.4 Cryopreservation of adherent versus suspension hPSC colonies  
In view of the poor survival rates obtained after cryopreservation of hPSCs in suspension 
using the slow-cooling rapid thawing method, some authors decided to test cryopreservation 
of adherent cells. This decision was based on previous studies done with certain cell types 
difficult to preserve. For example, hepatocytes cryopreserved in alginate gels display a higher 
viability and lower apoptotic activity than hepatocytes cryopreserved in suspension (Mahler et 
al., 2003). Similarly, hepatocytes sandwiched between two layers of collagen provide enhanced 
viability and protein secretion compared with cells preserved in solution (Birraux et al., 2002; 
Koebe et al., 1990; Koebe et al., 1999). Taking these results as a proof of principle, hESCs were 
successfully cryopreserved as adherent colonies in 24 well plates in medium containing 
10% DMSO + 30% FBS by Ji et al (Ji et al., 2004). This approach demonstrated that hESCs 
frozen as adherent colonies were five times more viable than clumps of colonies frozen in 
suspension. In addition, encapsulation of hESCs colonies inside MatrigelTM for 1 or 2 days 
increased viability significantly respect to unencapsulated adherent frozen colonies or colonies 
encapsulated for just 1 h. The percentage of adherent hESC colonies recovered 1 to 2 weeks 
after cryopreservation was about 80-90% and almost no differentiation was detected. In 
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contrast, less than 2% of hESC colonies attached when frozen in suspension. A recent work by 
Katkov et al reported a refinement of the technique cryopreserving adherent iPSC colonies in 
the presence of ethylene glycol as a cryoprotectant and using a six-step programmed protocol 
(Katkov et al., 2011). Preservation of iPSCs under these conditions induced a six-fold increase 
in cell recovery after thawing respect the standard cryopreservation of cell clumps by the slow-
freezing rapid thawing method (Katkov et al., 2011). Two mechanisms are postulated to 
explain the increased viability obtained preserving hESCs as adherent colonies. The first is that 
hESC colonies do not have to settle to the surface and attach. This is a decisive process for the 
survival of hPSC colonies frozen in suspension that is rarely achieved due to the massive cell 
death or cell damage experienced within the colony during cryopreservation. Second, the 
maintenance of a continuous extracellular matrix signaling may also play a role in the 
enhanced viability and reduced differentiation of hESCs cryopreserved in an adherent state 
(Ji et al., 2004). The disadvantage of this technique is that large scale storage is not feasible 
because hPSCs attached to plates cannot be stored at high density. In addition, culture plates 
are unable to be sealed like cryovials, increasing the risk of sample cross-contamination during 
storage in liquid nitrogen. However, methodologies such as preservation on microcarriers 
might provide the advantages of freezing adherent cells at higher densities that are not 
possible on flat surfaces. This is what has been described by Nie et al, who used Cytodex 3 
microcarriers to cryopreserve adherent hESCs (Nie et al., 2009). These microcarriers consisted 
of a thin layer of denatured collagen covalently coupled to a matrix of cross-linked dextran. 
They were modified with MatrigelTM or irradiated MEF to enhance the adhesion of hESC 
colonies. In this work it was first demonstrated that hESCs colonies were effectively expanded 
in a pluripotent, undifferentiated state on both types of microcarriers (MatrigelTM and MEF 
coated). Then cryopreservation utilizing this system was compared to standard freezing of 
hESC colonies in suspension. hESCs-microcarriers were suspended in freezing medium 
consisting in 10%DMSO and 30%FBS at a cell density of 1x106 cells/ml on 10 cm2 
microcarriers. The suspension was transferred to cryovials, frozen inside a freezing container 
at a cooling rate of -1ºC/min and moved into liquid nitrogen. Seven days after thawing 
viability was assessed by counting the number of cells. This number was compared to that of 
the conventional hESCs slow freezing method. Cryopreservation on microcarriers resulted in 
1.7 times the recovery of hESCs frozen in free suspension (Nie et al., 2009). Although the 
enhancement of cell recovery is not very promising, further optimization of this methodology 
holds a great potential for future larger-scale cryopreservation. 
3.5 Cryopreservation of dissociated single hPSCs versus clumps of colonies  
hPSCs are colony-forming social cells that present a high vulnerability to apoptosis upon 
cellular detachment and dissociation (Amit et al., 2000; Watanabe et al., 2007). These 
characteristics could explain why most of the cryopreservation protocols rely on hPSCs small 
clumps to improve survival rates (Heng et al., 2006; Reubinoff et al., 2001; Richards et al., 2004; 
Zhou et al., 2004). However, the cryopreservation of clumps presents some associated 
problems such as limitations on cryoprotectant exposure inside the clump. In this sense, T’Joen 
et al demonstrated that the application of a cell dissociation solution before freezing, thereby 
creating a mixed population of very small hESC clumps and single cells, increased the 
recovery rate after cryopreservation (T'joen et al., 2011). In addition, the use of hPSC colony 
clumps also prevents a good estimation of freezing-thawing efficiency, as precise cell numbers 
cannot be estimated. Therefore, development of cryopreservation protocols for dissociated 
hPSCs is a pre-requisite for the widespread use of these cells in basic or clinical research.  
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Most of the studies carried out so far for the cryopreservation of dissociated hPSCs involved 
the usage of ROCK inhibitors (usually 10µM of Y-27632), since in its absence very few or none 
colonies are obtained. This inhibitor has been reported to significantly increase the survival 
rate of frozen/thawed single hESC  as well as iPSCs (Claassen et al., 2009; Li et al., 2009; 
Martin-Ibanez et al., 2008; Mollamohammadi et al., 2009; Xu et al., 2010a; Xu et al., 2010b). 
Recent studies have demonstrated that Y-27632 increased not only the survival rate but also 
the adhesion of frozen–thawed dissociated single hPSCs in the presence and absence of feeder 
cells (Claassen et al., 2009; Katkov et al., 2011; Li et al., 2009; Martin-Ibanez et al., 2008; 
Mollamohammadi et al., 2009; Xu et al., 2010a; Xu et al., 2010b). In fact, Li et al. proposed that 
Y-27632 does not block apoptotic pathways, but rather prevents hPSCs from sensing their 
external environment, giving them time to make important cell-cell interactions and thus 
allowing them to escape anoikis (Krawetz et al., 2009; Li et al., 2009). Moreover, 
Mollamohammadi et al  showed by RT-PCR analysis that the expression of integrin chains aV, 
a6 and b1 increased significantly in the presence of ROCK inhibitor (Mollamohammadi et al., 
2009). They proposed that this increase in integrins expression may account for the 
maintenance of an undifferentiated state and an increase in cell adhesion of hESCs and iPSCs 
to the substrate allowing better cloning efficiency (Mollamohammadi et al., 2009).  
The usage of ROCK inhibitors for continuous treatments has not induced any adverse 
effects on hPSCs pluripotency or chromosomal stability, even after substantial number of 
passages (Mollamohammadi et al., 2009; Watanabe et al., 2007). ROCK inhibitors such as Y-
27632 or Fasudil are already used clinically in cardiovascular therapies (Hu & Lee, 2005), 
suggesting that they are safe for the treatment of hPSCs. Although the exact mechanism of 
action of ROCK inhibitors is, at the moment, unknown and a lot of cross talks between 
signaling pathways occur, the usage of this compound opens a new field of study to 
improve hPSCs cryopreservation and culture protocols. 
3.6 Controlled-rate cryopreservation 
The cooling rate is one of the cryobiological variables associated with damage during slow-
cooling (Figure 2). When the cooling process is rapid, intracellular ice crystals form before 
complete cellular dehydration has occurred. These ice crystals disrupt cellular organelles and 
membranes and lead to cell death during the recovery (thawing) process. On the other hand, 
when the cooling process is slow, free intracellular water is osmotically pulled from the cells 
resulting in complete cellular dehydration and shrinkage. This can also cause cellular death 
but there is little agreement on the mechanisms involved. However, when the cooling rate is 
slow enough to prevent intracellular ice formation, but fast enough to avoid serious 
dehydration effects, cells may be able to survive the freezing and thawing process. This 
survival zone or window is readily observed in many bacteria and other prokaryotes, but for 
most eukaryotic cells it is nonexistent or very difficult to find without using cryoprotectants. 
These agents have little effect on the damage caused by fast freezing (intracellular ice crystal 
formation), but rather prevent or lessen the damage caused by slow freezing (dehydration and 
shrinkage) (Figure 2) (Mazur, 1984). Thus, a tight control of the cooling rate is crucial to reduce 
cellular damage during cryopreservation, even in the presence of CPAs. This is achieved by 
the usage of programmable freezers. These devices, although expensive and not always 
available, are technically more reliable and reproducible. Several works have studied the 
relevance of programmable freezers for the cryopreservation of hPSCs. Ware et al reported 
survival rates of 60-70% with no apparent increase in differentiation using DMSO as a 
cryoprotectant, a control rate freezing device and straws as containers (Ware et al., 2005). The 
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results of this study identified three critical factors for successful hESCs freezing: ice crystal 
seed at some point above the temperature of spontaneous intracellular ice formation (between 
-7ºC and -12ºC), an appropriate freezing rate (between -0,3ºC and -1,8ºC/min) and rapid 
thawing (at 25-37ºC) (Ware et al., 2005). Another study optimizing the same critical factors 
described an improved protocol consisting in: cooling the sample from 0 ºC to -35 ºC at a 
cooling rate of -0.5ºC/min, seeding at -10 ºC before being plunged immediately into the liquid 
nitrogen and rapid thawing. Under these conditions a survival rate of 80% was obtained (Yang 
et al., 2006). A successful usage of programmable freezing for the cryopreservation of adherent 
iPSCs has also been recently described (Katkov et al., 2011). The authors developed a six step 
programmed protocol including : 1) -1ºC/min from 0ºC (addition of CPA on ice) to -10ºC; 2) 
hold for 30 min at -10ºC; 3) -3ºC/min to -40ºC; 4) -1ºC/min to -60ºC; 5) -0.33ºC/min to -80ºC 
and 6) hold at -80ºC for 5 min and then transfer to liquid nitrogen. Adherent iPSC colonies 
cryopreserved using ethylene glycol as a CPA under these conditions showed a 63% recovery, 
which represents a 6 fold increase respect the preservation without a programmable freezer 
using DMSO (Katkov et al., 2011).  
 
Fig. 2. Effects occurring during the cryopreservation of cells at different cooling rates. When 
the cooling process starts, ice crystals formation is induced and free intracellular water is 
osmotically pulled from the cells. If the cooling process is slow this effect lead to cellular cell 
death by dehydration and shrinkage. In contrast, if the cooling process is rapid, intracellular 
ice crystals form before complete cellular dehydration has occurred. These crystals induce 
cell death by cellular organelles and membrane disruption during the thawing process. An 
optimal cooling rate together with the usage of cryoprotectants in the freezing media avoids 
dehydration effects and intracellular ice formation allowing cell survival after thawing. 
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Rapid cooling 
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Dehydration 
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A recent report made an interesting comparison of three methods of cryopreservation of 
hESC clumps including: conventional slow freezing-rapid thawing using cryovials, 
vitrification and programmable cryopreservation in plastic straws (Li et al., 2010b). 
Assessing the efficiency of cryopreservation by counting the number of attached 
undifferentiated colonies 1-2 days and 7-8 days after thawing they reached the conclusion 
that conventional cryopreservation may not be appropriated for hESCs preservation since 
few colonies attached and most of them were differentiated. The usage of a programmable 
freezer increased significantly the cryopreservation efficiency (~50% colony recovery respect 
to ~5% of conventional freezing), although it was not better than the high efficiency 
obtained by vitrification (80-90% colony recovery). Both methodologies maintain unaffected 
the pluripotency and normal karyotype of the cells (Li et al., 2010b). Another comparative 
study published at the same time reported lower survival rates after programmable 
cryopreservation of hESC clumps (10-20% survival colonies), although they were 
significantly higher than the ones obtained after conventional slow-freezing (4-8%) (Lee et 
al., 2010). In this study the best cryopreservation condition was obtained using a stepwise 
transfer method for hESC clumps, which consisted in using a series of solutions with 
increasing serum replacement and DMSO concentrations to achieve a stepwise equilibration 
before freezing. The same inverse process was performed after thawing in order to 
gradually rehydrate the cells. The combination of stepwise methods with programmable 
freezers yielded survival rates of 30-50% with low numbers of differentiated cells (Lee et al., 
2010).  
3.7 Cryopreservation in xeno-free conditions  
Clinical application of hPSCs would need hESC and iPSC lines derived, cultured, 
differentiated and cryopreserved in xeno-free conditions following good manufacturing 
practice (GMP) regulations. Several attempts to improve hPSCs culture conditions have 
been reported. These advances include: the derivation of clinical grade hESC and iPSC lines, 
the use of conditioned media together with MatrigelTM as an attachment substrate for hPSCs 
culture and the derivation and propagation of hESC lines on human feeder layers in xeno-
free culture media (Amit et al., 2004; Hovatta et al., 2003; Rajala et al., 2007; Rajala et al., 
2010; Richards et al., 2002; Richards et al., 2003; Skottman et al., 2006; Unger et al., 2008). 
Some approaches have also been done in the cryopreservation field towards the 
development of xeno-free effective cryopreservation protocols. The first one was an 
optimization of the established vitrification method previously described by Reubinoff et al 
(Reubinoff et al., 2001; Richards et al., 2004). In this new method they reported the successful 
vitrification of hESCs in sealed closed straws, their storage in the vapor phase of liquid 
nitrogen and the substitution of FCS with human serum albumin as the major protein 
source in the cryoprotectant solution. This refinement of the technique allowed the removal 
of animal components from the cryopreservation medium, therefore lowering the risk of 
cross-transfer of viruses and other pathogens to the hESCs. Moreover, sealing the straws the 
authors also prevented contact with potentially contaminated liquid nitrogen during cooling 
and storage. The efficiency of hESCs preservation was similar to the original vitrification 
protocol (Richards et al., 2004). 
An effective serum and xeno-free chemically defined freezing procedure for hESCs and 
iPSCs has been recently developed (Holm et al., 2010). This protocol describes the usage of a 
commercially available freezing and post-thaw washing solution that presents the 
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advantage of being chemically defined, sterile and batch tested. The cryopreservation 
solution named STEM-CELLBANKERTM contains 10% DMSO, glucose and a high molecular 
weight polymer (undisclosed) used as a second cryoprotectant, all dissolved in phosphate-
buffered saline. hPSCs are preserved using this solution in cryovials and the slow-cooling 
rapid-thawing method, without any programmed freezer. After thawing, cells are recovered 
in the washing solution named CELLOTIONTM containing NaCl, centrifuged to eliminate 
cryoprotectants and plated down on a feeder layer of human mitotically inactivated 
fibroblasts. Post-thaw recovery was substantially increased without any detrimental impact 
on proliferation or differentiation (Holm et al., 2010). Similar cryopreservation yields were 
obtained for both hESCs preserved as clumps and iPSCs preserved as single cells without 
ROCK inhibitor treatment. Therefore, this is a simple and efficient system that enables the 
cryopreservation of large quantities of hPSCs in a chemically defined medium that is clinical 
grade compatible (Holm et al., 2010). Employing a similar protocol but using a home-made 
cryopreservation solution containing 10% DMSO and 90% KSR, Li et al reported the 
preservation of single hESCs in serum and feeder-free conditions in the presence of ROCK 
inhibitor during the first day after thawing (Li et al., 2009). 
4. Conclusion 
Understanding the mechanisms involved in the high vulnerability of hPSCs to the 
cryopreservation process is essential to develop efficient protocols for cryopreservation. 
Most of the research being undertaken over the last years is still empirical and few advances 
have been achieved in the identification of the pathways involved in the enhancement of cell 
survival induced by different factors, cryoprotectants or preservation systems. However, 
from the results obtained in these studies it is becoming increasingly clear that cell-cell 
adhesion and/or paracrine signaling between hPSCs are essential for survival and control of 
their undifferentiated state (Amit et al., 2000; Reubinoff et al., 2000; Thomson et al., 1998). 
Gap junctions and cell adhesion molecules are highly expressed in hESCs and have been 
implicated in these processes (De et al., 2002; Richards et al., 2004; Sathananthan et al., 2002; 
Wong et al., 2004; Wong et al., 2008). Therefore, disruption of these structures during 
cryopreservation due to ice crystal formation outside the cells may induce anoikis 
contributing to the poor recovery of hPSCs after slow cooling. However, a better 
understanding of this process together with a systematic study of the critical cryobiological 
variables is still needed to improve the already existing cryopreservation protocols. Further 
advances in the field would also require the development of reliable and standardized 
assays to measure not only immediate post-thaw recovery but also the ability of single cells 
or clumps to re-attach, proliferate and maintain pluripotency. Moreover, it is necessary to 
establish the n-points at which these assays should be applied, in order to allow direct 
quantitative comparisons between different cryopreservation methods that are not feasible 
at the moment. Thus, all present and future investigations would likely provide a 
reproducible effective and efficient cryopreservation protocol for hPSCs large-scale storage 
that will fulfill GMP requirements, permitting the widespread use of hPSCs in basic and/or 
clinical research.  
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